TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Dividend Stocks

    New to Investing? Avoid These 5 “Rookie” Mistakes

    Follow these five tips that will help you avoid common pitfalls of investing in stocks such as Valeant Pharmaceuticals Intl…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Best Long-Term Rebound Play on the TSX?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) looks like it's on the road to a rebound. Here's why investors may want to…

    Read more »

    Investing

    Aurora Cannabis Inc. Surges ~153% in a Month: Can it Catch Up to Canopy Growth Corp.?

    Are Aurora Cannabis Inc. (TSX:ACB) shares too hot to handle at current levels? Or is the company going after Canopy…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: If You’d Bought the Dip, You’re up

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has had a great month, and it could continue to ride that wave.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Opportunity or Value Trap?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has shown signs of improvement under Joseph Papa. Should investors take a risk on the…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is on the Path to Recovery

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) soared 17% on November 7 after the release of strong Q3 results and keeps rising.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Gives Back Controversial New Drug

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) announced this week the sale of the controversial female-libido-enhancing drug Addyi.

    Read more »

    Investing

    Why Canada Goose Holdings Inc.’s Strong Q2 Shouldn’t Convince You to Buy the Stock

    Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) had a very strong second quarter, but there are still some concerns investors should have about…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: A High-Risk/High-Reward Stock for Patient Rebound Hunters

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is picking up negative momentum. Should you buy the dip or follow the herd?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.’s Q3 Results Boosted by Non-Operating Items

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) released its Q3 results today. Results failed to show any sales growth or improved profitability from…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Has Thrown in the Towel: Should You?

    After giving up another revenue-generating asset, investors need to cut ties with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Shopify Inc. Reports Earnings, Shares Fall, But it’s Only the Beginning

    After failing to meet expectations, the fall of Shopify Inc. (TSX:SHOP)(NYSE:SHOP) may only be starting.

    Read more »